The Src family kinases (SFK) are a group of signalling molecules with important regulatory functions in inflammation and haemostasis. Leucocytes and platelets express multiple isoforms of the SFKs. Previous studies used broad-spectrum pharmacological inhibitors, or murine models deficient in multiple SFK isoforms, to demonstrate the functional consequences of deficiencies in SFK signalling. Here, we hypothesized that individual SFK operate in a non-redundant fashion in the thrombo-inflammatory recruitment of monocyte during atherosclerosis. Using in vitro adhesion assays and single SFK knockout mice crossed with the ApoE À/À model of atherosclerosis, we find that SFK signalling regulates platelet-dependent recruitment of monocytes.
However, patients at high risk of cardiovascular disease are already well served by antiplatelet agents such as aspirin and the antagonists of the ADP receptor P2Y12 (eg Prasugrel and Ticagralor). [8] [9] [10] Although these show anti-inflammatory activity over and above their ability to prevent thrombosis, 11, 12 their use does not prevent progression of atherosclerosis in humans. 13 Thus, we require a different approach to target thrombo-inflammatory pathways with greater precision. We believe that targeting signalling pathways involved in the activation and function of both platelets and leucocytes represent tractable targets for such interventions, and the Src family kinases (SFKs) may be appropriate due to their importance in regulating the function of both cell types.
In mammals, SFKs are a group of 8 structurally related protein tyrosine kinases. 14 Src, Fyn and Yes are ubiquitously expressed, 15 although distinct isoforms dominate expression in different cells. [16] [17] [18] Lyn, Hck, Fgr, Blk and Lck however, are predominantly and differentially expressed in the various cells types of the haematopoietic lineage, ie leucocytes and platelets. 19 and b2 integrins essential for leucocyte trafficking. [22] [23] [24] In addition, leucocyte functions that may be dependent on outside-in signals originating from ligand bound integrins are also affected in SFK-deficient animals. 25, 26 For example, initiation of the respiratory burst, degranulation and phagocytosis are known to be impaired in the absence of SFK signalling. 27, 28 SFK are also essential for platelet activation. They mediate rapid activation down stream of adhesion receptors such as GPIb-IX-V (von Willebrand receptor 29 ) and GPVI (collagen receptor 30 ), they promote maximal platelet activity by signalling downstream of G-coupled receptors for secondary mediators such as ADP, 31 and they regulate outside-in signals from extra-cellular matrix binding integrins such aIIbb3, required for efficient activation, spreading, secretion and clot retraction. 32 Importantly however, the roles of SFK in thrombo-inflammatory pathways of leucocyte recruitment have not been investigated to date. Here, we show that the platelet-dependent recruitment of monocytes in in vitro models of vascular inflammation was strongly dependent upon SFK's in both murine and human systems. Using genetically modified mice in which the most (Lyn) and least (Fgr) abundant platelet SFK isoforms had been knocked out independently, the platelets of both Fgr À/À and Lyn À/À deficient animals showed greatly retarded activation responses to ADP in vitro. When these platelets were used in functionally stringent thrombo-inflammatory models of leukcoyte recruitment in vitro, both strains showed significant deficiencies in leucocyte recruitment. We also observed dramatic reductions in the burden of disease in the Fgr vices, UK) for 6 weeks. We observed no sex differences in our analysis so both male and female data were included.
| Murine blood collection for in vitro studies
Murine blood was drawn by cardiac puncture from mice terminally anesthetized with CO 2 and taken into 100 lL sodium citrate and combined with 200 lL modified Tyrode buffer (137 mmol/L NaCl.
11.9 mmol/L NaHCO3, 0.4 mmol/L Na2HPO4, 2.7 mmol/L KCl, 1.1 mmol/L MgCl2, 20 mmol/L Hepes and 5.6 mmol/L glucose, pH 7.3). Blood was left at room temperature until further processing.
| Murine hematological and serum lipid analysis
Total white blood cell (WBC) counts and differential white cell counts were determined using the ABX Pentra 60 hematology analyser (Horiba, Northampton, UK). Non-anticoagulated blood was allowed to clot at room temperature for 1 hour then centrifuged at 20 000 g for 10 minutes. Serum was collected and stored at À20°C.
Serum triglyceride (Randox, Antrim, UK), free fatty acids (Abcam, Cambridge, UK), total cholesterol levels, HDL, LDL and glucose (Sentinel Diagnostics, Milan, Italy) were analysed via colorimetric assays. 
| Murine aorta isolation

| Human blood collection for in vitro studies
Venous blood from healthy volunteers was taken into 10% sodium citrate or EDTA.
| Preparation of platelet rich plasma
Platelet-rich plasma (PRP) was obtained from human and murine anti-coagulated blood by addition of modified Tyrode's buffer 1:5 to volume of whole blood and centrifugation at 3009 g for 10 minutes.
PRP was then removed and diluted to the required concentration with Tyrode's/Hepes buffer.
| Peripheral blood mononuclear cell isolation
Peripheral blood mononuclear cells (PBMCs) were isolated from human EDTA treated blood using the histopaque 1119 and 1077 gradient system (Sigma). Murine PBMCs were isolated using Lympholyte Mammal (Cedarlane Laboratorys). Briefly, 2 mL of EDTA treated Blood was diluted 1:1 with PBS and layered over 5 mL of Lympholyte mammal and centrifuged at 8009 g for 20 minutes at room temperature. PBMC layer was removed and diluted to 10 mL with PBS and centrifuged at 8009 g for 10 minutes at room temperature to pellet cells. Supernatant was removed and PBMCs were diluted to 1 9 10 6 cells/mL in PBS.
| Aggregometry
Platelet aggregation was monitored in 300 lL (2 9 10 8 /mL) PRP.
Aggregation was monitored by light transmission using a Born aggregometer (Alpha Laboratories, Eastleigh, Hants, UK) with high-speed stirring (1200 rpm) at 37°C. Agonists were added as 10-100-fold
concentrates. The transmission with PRP was expressed as a percentage of that with platelet-poor plasma.
| Flow cytometry analysis of P-selectin expression
Platelet-rich plasma was extracted as previously described. 
| Human flow-based adhesion assay on VWF
Blood was collected as previously described. Capillary tubes 
| Murine flow-based adhesion assay on VWF
Blood was collected as previously described. Capillary tubes (0.1 9 1.0 mm, 50 mm long; Camlab) were coated with 3.1 g/L anti-Human VWF (Dako, Cambridge, UK-A0082) overnight at 4°C. The capillaries were washed and blocked with PBS containing 2% BSA for 1 hour at room temperature, followed by murine plasma for 1 hour at room temperature. Capillaries were then connected to a multi-valve flow-based system containing reservoirs filled with either anti-coagulated blood, PBMCs or PBSA. The 
| Statistical analysis
Experimental data were analysed using GraphPad Prism software (GraphPad, La Jolla, USA-version 5) or SPSS (IBM). Normality of data was checked using the Shapiro-Wilk normality test when n ≤ 10 or the D'Agostino & pearson normality test when n ≥ 10.
Non-parametric tests were used when the data did not pass the normality tests. Differences between individual treatments or groups were analysed by paired or unpaired t test as appropriate.
One or two-way analysis of variance (ANOVA) was used for multiple group comparison followed by a post hoc analysis where appropriate, using Bonferroni test for comparisons between groups or Dunnet tests for comparisons to a control group. P values of ≤.05 were considered significant. Data are expressed as mean AE standard error of the mean (SEM) when n ≥ 8 or standard deviation (SD) when n ≤ 8. any, bleeding diathesis, when the haemostatic system is tasked in vivo. 32, 33 However, studying the aggregation of purified platelets in stirred suspensions has no physiological correlate, and induction of efficient aggregation requires high levels of agonist.
| Study approval
Indeed, in our own experiments we saw little effect of the genetic ablation of the single SFK isoforms, Lyn or Fgr, when platelet responses were tested in aggregomtery experiments using 10 or 30 lg/mL ADP. However, when we titrated ADP below such concentrations (1-5 lg/mL) we were able to see subtle but significant deficiencies in the aggregation responses of platelets isolated from either knockout strain (Supporting information Figure S2A ,B). The fact that differences in platelet function were discernible in aggregometry experiments immediately prompted a detailed analysis in stringent flow-based adhesion assays using physiological substrates for platelet recruitment. When CPDA anti-coagulated whole blood was perfused at a wall shear rate of 1000 s À1 across VWF immobilized in glass microslides, a large population of rapidly rolling platelets was established. This was the case for human blood perfused across hVWF ( Figure 1A ) and for murine blood (Figure 1B) perfused across mVWF. These interactions were not stable and after washout of blood, few platelets remained on the adhesive surface ( Figure 1A The loss of monocyte adhesion to the extent observed was surprising, as we and others have previously shown that even sparsely adherent platelets (ie <1% coverage) can support substantial levels of leucocyte tethering and adhesion through P-selectin. 6, 34 In addition, using this flow system, we observed that efficient recruitment of human neutrophils on platelets bound to VWF (Supporting information Figure S3 ).
Treatment of whole blood with Dasatinib (20 lmol/L) also significantly decreased neutrophil adhesion by 89%.
Flow cytometry analysis of platelets activated by ADP in the presence or absence of dasatanib provided the rationale for the observed inhibition of monocyte recruitment by the remaining adherent platelets (%2%-5% coverage in the presence of dasatanib).
In both human and murine platelets, dasatanib inhibited the expression of platelet P-selectin at ADP concentrations as high as 30 lmol/L (Figure 2A-D) .
In more stringent cell-based models of vascular inflammation, we have previously identified TGF-b1 as a potent agonist of VWF expression on EC. Indeed, TGF-b1 can promote platelet adhesion and secondary leucocyte recruitment both in vitro 6 and in vivo. 6 Using an in vitro flow-based assay, we observed that stimulation of human EC with TGF-b1 (10 ng/mL) resulted in substantial adhesion of human platelets from flowing whole blood ( Figure 2E ), which in turn supported the secondary recruitment of monocytes from the flowing blood.
Importantly, addition of dasatanib (10 lmol/L) to blood prior to perfusion across activated EC, significantly reduced platelet coverage on TGF-b1 stimulated EC. In turn, this had a marked effect on the efficiency of secondary recruitment of monocytes, resulting in a significant reduction in their adhesion ( Figure 2E ,F).
| Genetic deletion of single SFK isoforms in mice alters platelet activation and inhibits the thrombo-inflammatory recruitment of monocytes
Having demonstrated that the removal of redundant SFK had dramatic effects on the thrombo-inflammatory recruitment of The level of monocyte and platelet adhesion was assessed by phase contrast microscopy (n = 3). Data are shown as mean AE SD. *P < .05, **P < .01 compared to the ADP positive control using one-way ANOVA followed by a Dunnett's post-test leucocytes, we tested whether platelets deficient in single SFK isoforms showed any deficit in thrombo-inflammatory activity. Using whole blood taken from animals with a complete knock out of the most and least abundant SFK's in platelets (Lyn and Fgr, respectively), we found that platelets were readily recruited to and rolled upon immobilized VWF. The number of adherent platelets did not F I G U R E 2 Dasatinib inhibits platelet P-selectin expression in both human and mouse platelets and prevents the adhesion of platelets and monocytes to TGF-b1 stimulated endothelium under flow conditions. A, Representative flow cytometry plots of P-selectin expression in human or (B) murine platelet-rich plasma (PRP) prepared from freshly drawn blood and stimulated with 30 lmol/L ADP AE 20 lmol/L Dasatinib. C, Mean fluorescent intensity (MFI) of P-selectin staining on human or (D) murine platelets. E, The effect of Dasatanib on platelet and (F) monocyte recruitment to TGF-b1 stimulated endothelial cells. Dasatanib (4 lmol/L) was added to blood 15 min prior to perfusion across EC and the level of monocyte and platelet adhesion assessed by phase contrast microscopy (n = 4). Data are mean AE SD. *P < .05, **P < .01, vs ADP only control (C, D) vs blood perfused in the absence of Dasatanib (E, F) using one-way ANOVA followed by a Dunnett's post-test differ in magnitude in wild type or SFK knockout animals. However, upon super perfusion of ADP across rolling platelets, dramatic differences in platelet function were evident. Wild type platelets became rapidly activated and spread on the adhesive substrate forming microthrombi (Figure 3A,D) . Lyn À/À platelets did not become activated, and were washed from the system as they rolled on the VWF substrate ( Figure 3B,D Figure 3C,D) .
The acquisition of such a profound phenotype in single SFK knockout animals prompted us to determine whether the expression of P-selectin from a-granules, which would be required the thrombo-inflammatory secondary recruitment of monocytes, was also affected in animals deficient in a single SFK isoform. In both Lyn À/À and Fgr À/À platelets, P-selectin expression was dramatically reduced in the presence of ADP ( Figure 3E,F) . Indeed, the levels of inhibition of degranulation (and therefore P-selectin expression) were not dissimilar to that seen in wild type platelets pre-treated with disatanib ( Figure 2B,D) . ). The level of monocyte was adhesion assessed by phase contrast microscopy (n = 18). Data are mean AE SEM. Data are shown as mean AE SD. *P < .05, **P < .01 compared to the WT ADP positive control using one-way ANOVA followed by a Dunnett's post-test Because the effects of knocking out single SFK isoforms on platelet function were so profound, we tested whether these extended to the secondary, thrombo-inflammatory recruitment of monocytes. To do this we established populations of wild type,
Fgr
À/À or Lyn À/À platelets on immobilized VWF. Following activation by ADP, we perfused isolated murine monocytes across the activated platelets. The secondary recruitment of wild type leucocytes by ADP stimulated Lyn À/À platelets was dramatically (>60%) reduced, when compared to recruitment by WT platelets (Figure 3G) . A similar but less robust inhibition of leucocyte recruitment was evident when Fgr À/À platelets were compared to wild type ( Figure 3H ).
The use of an ex vivo adhesion assay also allowed us to determine whether the loss of SFK signalling in leucocytes was redundant in the process of recruitment, as recently indicated by Kovacs et al 35 In fact, when we used mononuclear leucocytes isolated from the Lyn À/À or the Fgr À/À strains, and measured the levels of their recruitment by wild-type platelets, we observed significant reductions in the efficiency of secondary recruitment in both the Lyn Table S1 ). ApoE À/À animals fed a high fat diet (HFD) for 6 weeks demonstrated a significant level of plaque formation equivalent to %15% plaque coverage over the whole aorta ( Figure 4A,B) .
Interestingly, the loss of either Lyn or Fgr led to a dramatic decrease in disease burden over the whole aorta (Figure 4A ,B; >70% and 60% reduction in plaque coverage, respectively). Detailed analysis of the anatomically distinct regions of the aorta and the major branching arteries of the aortic arch, showed that disease was reduced uniformly across the arterial tree ( Figure 4C ). Interestingly, in both the 
| DISCUSSION
Direct evidence that thrombo-inflammatory pathways are relevant to the development of vascular disease comes from murine models of atherosclerosis, where inhibition of platelet adhesion, or induction of thrombocytopenia, significantly reduced the burden of atheroma. 5, 36, 37 In addition, instillation of activated platelets exacerbates arterial disease in such models. 5 There is also direct evidence that platelet P-selectin plays a role in plaque formation in the ApoE À/À mouse. 38, 39 Other studies demonstrate that platelet-derived chemokines such as CCL5 can selectively recruit monocytes in these models. 40, 41 In addition the preferential recruitment of monocytes to TGF-b1 stimulated EC in vitro and in vivo is mediated by platelet bridges. 6 TGF-b1 promotes the expression of a matrix of VWF on the EC surface which recruits platelets from flowing blood. Upon platelet activation at the EC surface by ADP, monocytes are in turn recruited by platelet P-selectin. 6, 42 Experiments such as these, that
show the marked effects of modulating thrombo-inflammation, indicate that interruption of these pathways may have utility in regulating the cellular pathology of diseases such as atherosclerosis.
Moreover, this could be an important target for such diseases, as thrombo-inflammatory pathways may well fall without the control of more conventional therapies for regulating inflammation in other diseases.
The efficacy of knocking out a single SFK in such experiments is interesting, particularly so as it is not even necessary to target the most highly expressed SFK to modulate the activation of platelets in these physiological assays. In murine platelets, the predominant SFKs expressed in order of their abundance are Lyn, Src, Fyn and Fgr. 43 Indeed the 2 SFK targeted in the current study (Lyn and Fgr) show nearly a 100-fold differential in expression in platelets. 43 Interestingly, the responses to activation of platelets from the Fgr À/À and Lyn À/À animals were distinct, demonstrating that these SFK regulate different pathways downstream of activation with ADP. However, it would appear that both pathways must be integrated for efficient platelet activation, spreading and P-selectin expression and importantly, their functions are not redundant.
In the context of thrombo-inflammatory pathways of monocyte recruitment in atheromatous disease, it appears that SFK play a critical role in disease progression. Undoubtedly, the most unexpected, and thus the most interesting aspect of our studies has
been the ability to demonstrate that SFK signalling is not redundant when physiologically exacting models of platelet and leucocyte function are used to probe these pathways. Non-redundant functions of SFK have previously been observed, for example in the central nervous system. However, in this study the activity of Fyn was involved in signal transduction from a single membrane receptor (NCAM-140) feeding back on the process of neuronal migration. 20 In the immune system and during an inflammatory response, multiple adhesion and activation receptors feed into the leucocyte trafficking process, and it is assumed that redundancy occurs due to the number of alternative routes by which recruitment can be facilitated. Thus, it is important to appreciate that even in a process | 4325 involving multiple cell types (here, monocytes, platelets and endothelial cells), in a paradigm requiring multiple interactions between adhesion and activation pathways, the loss of function of a single SFK can have dramatic moderating effects on disease burden in integrated models of arterial disease. These benefits appear to be achievable without undue influence on the haemostatic and immune systems, as no significant bleeding phenotypes are reported in the single SFK knockout strains. 43 Certainly, we observed no excess morbidity or mortality in our own SFK knockout cohorts over the duration of these experiments when compared to wild type or ApoE À/À control animals. In addition, we observed no changes in plaque stability in these animals as collagen content and cellularity did not differ between the groups. This is interesting as it implies that targeting single SFK's therapeutically would not result in detrimental changes in plaque morphology that might lead to an increased risk of thrombotic complications. Thus, we believe that developing specific inhibitors to SFK isoforms is a rational approach to targeting disease pathways.
